Skip to Main Content

Author Details

Melanie Spears
Ontario Institute for Cancer Research
2008
18
10
PMIDPaper TitleJournal TitlePublished Year
31322299Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture.Adv Mater2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
29618387Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.J Ovarian Res2018
28659176ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.Genome Med2017
27056899A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.Oncotarget2016
26852132Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.Breast Cancer Res2016
26372731A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials.Oncotarget2015
24402423Validated or not validated? That is the question.J Natl Cancer Inst2014
25312014Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance.BMC Cancer2014
23152120Authors' reply.J Pathol2013
21390497The p160 ER co-regulators predict outcome in ER negative breast cancer.Breast Cancer Res Treat2012
22562124Expression of activated type I receptor tyrosine kinases in early breast cancer.Breast Cancer Res Treat2012
22430898Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression.J Pathol2012
21638049In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.Breast Cancer Res Treat2012
20700126In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues.Br J Cancer2010
19456271The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.Expert Opin Ther Targets2009
19925033Human epidermal growth factor receptor dimerization analysis in breast cancer diagnosis: potential for improving testing accuracy and treatment selection.Mol Diagn Ther2009
20477393Type I receptor tyrosine kinases as predictive or prognostic markers in early breast cancer.Biomark Med2008
  • 1 - 18 of 18

Recommended Authors

Martin Sj??str??m
University of California-San Francisco
Career Start Year 2013
Number of shared co-authors 1
Konstantinos Tryfonidis
Merck & Co., Inc.
Career Start Year 2011
Number of shared co-authors 2
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 2
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 7
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 5
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 1
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 3
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 1
Ingrid A Mayer
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 4
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year 2000
Number of shared co-authors 10
Massimo Cristofanilli
Weill Cornell School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 4
Giuseppe Curigliano
University of Milan
Career Start Year 1996
Number of shared co-authors 4
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 2
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 0
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 1
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 0
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 9
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 1
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 1
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 4
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 8
Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Career Start Year 1984
Number of shared co-authors 0
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 2
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 3

Collaborators

John M S Bartlett
University of Edinburgh
Co-authored papers 18
Karen J Taylor
University of Edinburgh
Co-authored papers 6
Nicola Lyttle
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 6
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 5
Paul C Boutros
University of California los angeles
Co-authored papers 5
Alison F Munro
Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital
Co-authored papers 4
Carrie A Cunningham
Massachusetts General Hospital
Co-authored papers 4
Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
Co-authored papers 3
Chris Twelves
Leeds Teaching Hospitals NHS Trust, University of Leeds
Co-authored papers 3
Linda Liao
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
Elizabeth Mallon
Queen Elizabeth University Hospital
Co-authored papers 3
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers 2
Mark N Levine
Juravinski Hospital and Cancer Center
Co-authored papers 2
Richard Marcellus
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 2
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers 2
Mary Anne Quintayo
Ontario Institute of Cancer Research, MaRS Institute
Co-authored papers 2
Lois Shepherd
Queens University
Co-authored papers 2
Quang M Trinh
Ontario Institute for Cancer Research
Co-authored papers 2
Amila Sarac
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Alan Mackay
Co-authored papers 1
Elizabeth N Kornaga
Tom Baker Cancer Centre
Co-authored papers 1
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers 1
Maryou B Lambros
The Institute of Cancer Research
Co-authored papers 1
Marsela Braunstein
Princess Margaret Cancer Centre
Co-authored papers 1
Gun Ho Jang
Ontario Institute for Cancer Research
Co-authored papers 1
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 1
Cheryl Crozier
Ontario Institute for Cancer Research
Co-authored papers 1
Julie Livingstone
University of California los angeles
Co-authored papers 1
Nazleen C Lobo
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Release 1.2